Ginkgo Bioworks Raises $2.5 billion SPAC
Ginkgo Bioworks has raised $2,500M in SPAC funding led by Various, with participation from Various (SPAC). AI cell programming platform for synthetic biology.
SPAC$2.5 billionTotal tracked $2.5 billionBoston, MA
What it does
AI cell programming platform for synthetic biology.
Traction
Ginkgo Bioworks is continuing to scale after securing $2,500M in SPAC funding led by Various, with participation from Various (SPAC).
Trend impact
Ginkgo Bioworks's financing points to investor interest in Healthcare & Life Sciences, but the current source bundle does not yet support a sharper market-disruption claim.
Funding history
- September 1, 2021 · SPAC · $2.5 billion · Various (SPAC)
Products & services
- Healthcare & Life Sciences workflow monitoring tied to the funding announcement
- Customer-facing product described on the company website
- Operational tooling for healthcare & life sciences teams
- Data capture and reporting across core business processes
- Team expansion support funded by the latest round